Literature DB >> 23680551

An integrated strategy for in vivo metabolite profiling using high-resolution mass spectrometry based data processing techniques.

Jian Guo1, Minli Zhang, Charles S Elmore, Karthick Vishwanathan.   

Abstract

An ongoing challenge of drug metabolite profiling is to detect and identify unknown or low-level metabolites in complex biological matrices. Here we present a generic strategy for metabolite detection using multiple accurate-mass-based data processing tools via the analysis of rat samples of two model drug candidates, AZD6280 and AZ12488024. First, the function of isotopic pattern recognition was proved to be highly effective in the detection of metabolites derived from [(14)C]-AZD6280 that possesses a distinct isotopic pattern. The metabolites revealed using this approach were in excellent qualitative correlation to those observed in radiochromatograms. Second, the effectiveness of accurate mass based untargeted data mining tools such as background subtraction, mass defect filtering, or a data mining package (MZmine) used for metabolomic analysis in detection of metabolites of [(14)C]-AZ12488024 in rat urine, feces, bile and plasma samples was examined and a total of 33 metabolites of AZ12488024 were detected. Among them, at least 16 metabolites were only detected by the aid of the data mining packages and not via radiochromatograms. New metabolic pathways such as S-oxidation and thiomethylation reactions occurring on the thiazole ring were proposed based on the processed data. The results of these experiments also demonstrated that accurate mass-based mass defect filtering (MDF) and data mining techniques used in metabolomics are complementary and can be valuable tools for delineating low-level metabolites in complex matrices. Furthermore, the application of distinct multiple data-mining algorithms in parallel, or in tandem, can be effective for rapidly profiling in vivo drug metabolites.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23680551     DOI: 10.1016/j.aca.2013.04.012

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  6 in total

1.  An LC-MS-based lipidomics pre-processing framework underpins rapid hypothesis generation towards CHO systems biotechnology.

Authors:  Hock Chuan Yeo; Shuwen Chen; Ying Swan Ho; Dong-Yup Lee
Journal:  Metabolomics       Date:  2018-07-09       Impact factor: 4.290

Review 2.  Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review.

Authors:  Abdul-Hamid Emwas; Claudio Luchinat; Paola Turano; Leonardo Tenori; Raja Roy; Reza M Salek; Danielle Ryan; Jasmeen S Merzaban; Rima Kaddurah-Daouk; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Yulan Wang; Lorraine Brennan; David S Wishart
Journal:  Metabolomics       Date:  2014-11-21       Impact factor: 4.290

3.  Synthesis of C-14 labeled GABAA α2/α3 selective partial agonists and the investigation of late-occurring and long-circulating metabolites of GABAA receptor modulator AZD7325.

Authors:  Markus Artelsmair; Chungang Gu; Richard J Lewis; Charles S Elmore
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-30       Impact factor: 1.921

Review 4.  Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways.

Authors:  Abdul-Hamid Emwas; Kacper Szczepski; Inas Al-Younis; Joanna Izabela Lachowicz; Mariusz Jaremko
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

Review 5.  Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry.

Authors:  Yang Yu; Changliang Yao; De-An Guo
Journal:  Acta Pharm Sin B       Date:  2021-02-26       Impact factor: 11.413

Review 6.  Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis.

Authors:  Abdul-Hamid Emwas; Raja Roy; Ryan T McKay; Danielle Ryan; Lorraine Brennan; Leonardo Tenori; Claudio Luchinat; Xin Gao; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Christoph Steinbeck; Reza M Salek; David S Wishart
Journal:  J Proteome Res       Date:  2016-01-20       Impact factor: 4.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.